Related Experiment Video
Updated: Jan 29, 2026

Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia
Published on: February 17, 2023
Predictive Value of Methods Measuring Platelet Activation for Ischemic Events in Patients Receiving Clopidogrel: A
Zhe Wang1,2, Qiufen Xie1, Qian Xiang1
1Department of Pharmacy, Peking University First Hospital, Beijing, China.
Insights
Light-transmission aggregometry (LTA), vasodilator-stimulated phosphoprotein (VASP), and VerifyNow effectively predict ischemic events in patients after percutaneous coronary intervention (PCI). These platelet function tests show considerable efficiency, with specific cut-off values recommended for clinical use.
Area of Science:
- Cardiology
- Clinical Chemistry
- Medical Diagnostics
Background:
- Percutaneous coronary intervention (PCI) is a common procedure for managing coronary artery disease.
- Monitoring platelet function is crucial to prevent ischemic events in patients undergoing PCI, especially those treated with antiplatelet agents like clopidogrel.
- Various methods exist to assess platelet reactivity, including light-transmission aggregometry (LTA), vasodilator-stimulated phosphoprotein (VASP) phosphorylation assays, and point-of-care devices like VerifyNow.
Purpose of the Study:
- To investigate and compare the efficiency and predictive value of LTA, VASP, and VerifyNow in identifying ischemic events in patients post-PCI.
- To analyze the sensitivity and specificity of these tests in predicting various clinical outcomes.
- To determine optimal cut-off values for each assay to predict ischemia.
Main Methods:
- A systematic review and meta-analysis of 31 studies involving 17,314 participants.
- Inclusion of studies utilizing LTA, VASP, or VerifyNow to predict ischemic events.
- Analysis of study quality and efficiency using Review Manager 5.3, calculating sensitivity, specificity, and summary ROC (sROC) curves.
Main Results:
- LTA, VASP, and VerifyNow demonstrated considerable efficiency in predicting ischemic clinical events.
- Subgroup analyses revealed varying sensitivities and specificities for predicting outcomes like cardiac death, myocardial infarction, and stent thrombosis.
- VerifyNow showed no statistically significant higher AUC of sROC compared to LTA and VASP for predicting ischemic events in clopidogrel-treated patients; suggested cut-off values are LTA: 56%, VASP: 50%, VerifyNow: 235.
Conclusions:
- LTA, VASP, and VerifyNow are valuable tools for predicting ischemic events in patients undergoing PCI.
- The predictive performance varies based on the specific outcome and time frame; LTA showed better prediction for outcomes >6 months, while VerifyNow was better within 6 months.
- The study provides recommended cut-off values to aid in the clinical interpretation of these platelet function tests.
Abstract:
This study investigates the efficiency and predictive value of light-transmission aggregometry (LTA), vasodilator-stimulated phosphoprotein (VASP) and VerifyNow for ischemia in patients undergoing percutaneous coronary intervention (PCI). Studies that used LTA, VASP or VerifyNow to predict ischemia were included, and their quality and efficiency were analyzed using Review Manager 5.3. The sensitivity and specificity of subgroup studies based on the outcome, cut-off value, and follow-up days were calculated and the summary ROC (sROC) curves were compared after having been fitted. Thirty-one studies including a total of 17,314 participants were analyzed. LTA, VASP and VerifyNow presented a considerable efficiency in predicting ischemic clinical events. In the subgroup analysis, the sensitivities of LTA, VASP and VerifyNow in predicting cardiac death, all-cause death, myocardial infarction, stent thrombosis, stroke, and revascularization were 0.40/0.63/0.62, 0.47/0.56/0.39, 0.40/0.48/0.60, 0.44/0.58/0.70, 0.29/not applicable/0.60 and 0.44/0.57/0.37, respectively and the specificities of LTA, VASP, and VerifyNow were 0.85/0.48/0.63, 0.73/0.52/0.63, 0.74/0.55/0.64, 0.75/0.47/0.61, 0.72/not applicable/ 0.61, and 0.70/0.47/0.67, respectively. LTA showed a higher sensitivity in predicting the outcomes over six months than those within six months, while VerifyNow prediction sensitivity was found to be higher within six months. Meanwhile, VerifyNow showed no statistically significant higher AUC of sROC in comparison to LTA and VASP in predicting ischemic events in patients undergoing clopidogrel treatment. The cut-off values of LTA, VASP and VerifyNow were suggested to be 56%, 50% and 235 respectively according to our study.
More Related Videos
08:21Point-of-Care Ultrasound: A Review of Ultrasound Parameters for Predicting Difficult Airways
Published on: April 7, 2023
05:49Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets
Published on: November 29, 2024
Related Concept Videos
Systematic Sampling Method
Systematic sampling is one of the simplest methods...
Review and Preview
Percentiles are a type of fractile that partition data into...
Review and Preview
Predicting Molecular Geometry
Receiver Operating Characteristic Plot
The Scientific Method